# A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult

> **NCT07632573** · PHASE1 · RECRUITING · sponsor: **Benethera (Shaoxing) Biotechnology Co., Ltd.** · enrollment: 68 (estimated)

## Conditions studied

- Ulcerative Colitis (UC)
- Ulcerative Colitis (Disorder)
- Ulcerative Colitis Acute
- IBD (Inflammatory Bowel Disease)
- CD - Crohn's Disease

## Interventions

- **DRUG:** BDHK-2009 Tablets
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07632573
- **Lead sponsor:** Benethera (Shaoxing) Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-28
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2026-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07632573

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07632573, "A Phase I Study to Evaluate the Safety/Tolerability of BDHK-2009 Tablets in Healthy Adult". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07632573. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*